跳至主要内容
临床试验/CTRI/2024/09/074347
CTRI/2024/09/074347招募中Phase 3 4

A randomised controlled clinical study to compare varnya effect of vidarikanda(Pueraria tuberosa DC) lepa with yashtimadhu(Glycyrrhiza glabra Linn) lepa in suntan(darkening of skin).

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurved hospital1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2024年10月15日最近更新:

试验速览

阶段
Phase 3 4
状态
招募中
发起方
入组人数
92
试验地点
1
主要终点
Decrease in the discoloration

研究概览

简要总结

The study will be intervened by the treatment of Vidarikanda lepa and Yashtimadhu lepa to Group A and Group B respectively. The efficacy of the drug will be assessed on the basis of subjective criteria for statistical analysis. scoring will be designed according to the severity of the symptoms. The subjective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment, and after follow-up. The effect of treatment results will be assessed in regard to clinical signs and symptoms on the basis of a grading and scoring system.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • History of sun rays exposure Trackers and athletic after heavy exposure to sun rays Not undergoing any skin treatment and cosmetic therapy from last 3 months.

排除标准

  • Suntan due to any other reason Suntan along with other skin disease and allergic to cosmetic products.

结局指标

主要结局

Decrease in the discoloration

时间窗: 21 days

次要结局

  • Oil content and moisture content of skin will be maintained(21 days)

研究者

发起方
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurved hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Vaishnavi Sanjayrao Talokar

Tilak Ayurved Mahavidyalaya, Pune

研究点 (1)

Loading locations...

相似试验